The results demonstrated that the ECA patients with high expression of LIMD2 showed enrichment of the following pathways: systemic lupus erythematosus, DNA replication, and T cell receptor signaling pathway (Supplementary Figures S4A–I). This evidence concerns the gene LIMD2 and systemic lupus erythematosus.